Free Trial
NASDAQ:XBIO

Xenetic Biosciences (XBIO) Stock Price, News & Analysis

Xenetic Biosciences logo
$2.80 +0.07 (+2.38%)
Closing price 05/2/2025 03:58 PM Eastern
Extended Trading
$2.88 +0.09 (+3.22%)
As of 05/2/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Xenetic Biosciences Stock (NASDAQ:XBIO)

Key Stats

Today's Range
$2.66
$2.85
50-Day Range
$2.30
$3.99
52-Week Range
$2.20
$5.20
Volume
11,613 shs
Average Volume
12,947 shs
Market Capitalization
$4.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.

Receive XBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xenetic Biosciences and its competitors with MarketBeat's FREE daily newsletter.

XBIO Stock News Headlines

Xenetic Biosciences (XBIO) Receives a Hold from H.C. Wainwright
The Man I Turn to In Times Like This
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.
Xenetic Biosciences Inc
3XB0.SG,0P0001N0OC,0 (3XB0.SG)
Xenetic Biosciences Inc (XBIO)
Xenetic Dips on Full-Year Results
See More Headlines

XBIO Stock Analysis - Frequently Asked Questions

Xenetic Biosciences' stock was trading at $3.99 at the beginning of the year. Since then, XBIO shares have decreased by 29.9% and is now trading at $2.7950.
View the best growth stocks for 2025 here
.

Xenetic Biosciences Inc (NASDAQ:XBIO) posted its quarterly earnings data on Tuesday, March, 18th. The company reported ($0.68) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by $0.48. The business earned $0.65 million during the quarter, compared to analysts' expectations of $0.18 million. Xenetic Biosciences had a negative trailing twelve-month return on equity of 49.51% and a negative net margin of 161.63%.

Xenetic Biosciences shares reverse split before market open on Monday, May 15th 2023. The 1-10 reverse split was announced on Monday, May 15th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of XBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Xenetic Biosciences investors own include FuelCell Energy (FCEL), OPKO Health (OPK), VBI Vaccines (VBIV), Bionano Genomics (BNGO), NIO (NIO), Sorrento Therapeutics (SRNE) and Vaxart (VXRT).

Company Calendar

Last Earnings
3/18/2025
Today
5/03/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:XBIO
Fax
N/A
Employees
4
Year Founded
2011

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,140,000.00
Net Margins
-161.63%
Pretax Margin
-161.59%

Debt

Sales & Book Value

Annual Sales
$2.50 million
Price / Cash Flow
N/A
Book Value
$6.36 per share
Price / Book
0.44

Miscellaneous

Free Float
1,315,000
Market Cap
$4.31 million
Optionable
Not Optionable
Beta
2.31

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:XBIO) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners